Clinical assessment of drug–drug interactions of tasimelteon, a novel dual melatonin receptor agonist

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|55|9|1004-1011

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.9, 2015-09, pp. : 1004-1011

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 525-533

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 1097-1108

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Next Generation of Drug Safety Science: Coupling Detection, Corroboration, and Validation to Discover Novel Drug Effects and Drug–Drug Interactions

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 177-179

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of drug–drug interactions for oncology therapies: in vitro–in vivo extrapolation model‐based risk assessment

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 6, 2015-06 ,pp. : 946-958

John Wiley & Sons Inc

Access to resources Recommend Favorite

P140: Drug‐drug interactions with novel all oral interferon free antiviral agents ‐ all issues solved?

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 89-90

John Wiley & Sons Inc

Access to resources Recommend Favorite